Is Cryosurgery or Curettage More Effective at Treating Seborrheic Keratoses?

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-07-31

Study Completion Date

2013-06-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Seborrheic keratoses (SK's) are very common, but harmless skin lesions that commonly appear during adult life. Patients with seborrheic keratoses frequently desire treatment due to symptoms of itching and irritation or for cosmetic purposes. Seborrheic keratoses can be easily removed and have been treated in a number of different ways. Two of the simplest and most successful ways to remove seborrheic keratoses are cryosurgery and curettage.

The investigators are conducting this study to see which of these two treatments has the best result.

Approximately 24-30 people will take part in this research study at the Hershey Medical Center.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1

NCT00865644

Neurofibromatosis Type 1 Cutaneous Neurofibromas

COMPLETED PHASE1

Investigating the Effect of Topical Imiquimod on Sebaceous Hyperplasia

NCT06840470

Sebaceous Hyperplasia

RECRUITING PHASE4

Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses

NCT00774787

Actinic Keratoses

COMPLETED PHASE4

Treatment of Dermatofibrosarcoma Protuberans in Patients 10 Years and Younger

NCT03381846

Dermatofibrosarcoma Protuberans

COMPLETED NA

Efficacy and Safety of a New Topical Formulation With Imiquimod (Limtop) Applied 1, 3 or 7 Times Weekly During 2 x 2 Weeks Treatment for Actinic Keratosis on the Head

NCT01611480

Actinic Keratosis

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Seborrheic Keratosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cryosurgery

One lesion on the patients' trunk or proximal extremities will be treated with cryosurgery.

Group Type ACTIVE_COMPARATOR

cryosurgery

Intervention Type PROCEDURE

freezing of lesion with liquid nitrogen

Curettage

One lesion on one side of the patients' trunk or proximal extremities will be treated by curettage.

Group Type ACTIVE_COMPARATOR

Curettage

Intervention Type PROCEDURE

the lesion will be anesthetized and destroyed with a curette.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

cryosurgery

freezing of lesion with liquid nitrogen

Intervention Type PROCEDURE

Curettage

the lesion will be anesthetized and destroyed with a curette.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* have at least 1 seborrheic keratosis on each side of his/her trunk or proximal extremities.
* be able to understand the consent form and evaluation of treatment questionnaire.

Exclusion Criteria

* Children \<18 are excluded from this study based on their inability to independently complete the informed consent and research associated questionnaire.

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes